Vitexin and an HMG-Co A reductase inhibitor prevent the risks of atherosclerosis in high-fat atherogenic diet fed rats
Vitexin, a flavone is known for its anti-oxidative and anti-inflammatory activities. The aim of this study was to investigate the effect of vitexin in HFAD induced atherosclerosis risks in rats. Atherosclerosis risks were induced in Albino Wistar rats by administering HFAD for 45 days. Vitexin (thre...
Main Authors: | Xiubing Lei, Yang Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-04-01
|
Series: | Journal of King Saud University: Science |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1018364720300392 |
Similar Items
-
Atherogenic Impact of Homocysteine: Can HMG-CoA Reductase Inhibitors Additionally Influence Hyperhomocysteinaemia?
by: Nikolic Tamara, et al.
Published: (2019-06-01) -
Pleiotropic effects of the HMG-CoA reductase inhibitors
by: Mihos CG, et al.
Published: (2011-04-01) -
The discovery and development of HMG-CoA reductase inhibitors.
by: A Endo
Published: (1992-11-01) -
Bioactive Pigments of Monascus purpureus Attributed to Antioxidant, HMG-CoA Reductase Inhibition and Anti-atherogenic Functions
by: H. P. Mohankumari, et al.
Published: (2021-02-01) -
The Effect of Atherogenic Diet with or without Enzyme Inhibitors on the Incidence and Progress
of Atherosclerosis in Rabbits
by: Masouad Pezeshkian, et al.
Published: (2011-04-01)